<h1>Medical tourism hubs proposed alongside Biopharma Shakti to boost domestic biologics production and clinical trial networks.</h1> Establish five regional medical hubs as integrated healthcare complexes combining clinical care, education and research, and launch Biopharma Shakti with a Rs 10,000 crore, five-year outlay to build domestic biologics and biosimilars capacity, create three new NIPERs and upgrade seven, establish 1,000 accredited clinical trial sites, and strengthen the central drug standards control organisation with a dedicated scientific review cadre for global-standard approvals.